Variety of Interpretation Systems for Human Immunodeficiency Virus Type 1 Genotyping: Confirmatory Information or Additional Confusion?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5852|3|4|373-382

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.3, Iss.4, 2003-12, pp. : 373-382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dimerization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase as an Antiviral Target

By  

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1879-1894

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. : 895-919

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Assembly of the Human Immunodeficiency Virus Type I

By  

Current Pharmaceutical Design, Vol. 10, Iss. 30, 2004-11 ,pp. : 3725-3739

Bentham Science Publishers

Access to resources Recommend Favorite

The Vif protein of Human Immunodeficiency Virus Type 1 (HIV-1): Enigmas and Solutions [General Articles]

By  

Current Medicinal Chemistry, Vol. 11, Iss. 2, 2004-01 ,pp. : 221-231

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and anti-human immunodeficiency virus type 1 activities of new peptido-nucleoside analogues

By Camplo M.   Niddam V.   Barthelemy P.   Faury P.   Mourier N.   Simon V.   Charvet A.   Trabaud C.   Graciet J.   Chermann J.   Kraus J.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 10, 1995-01 ,pp. : 789-800

Elsevier

Access to resources Recommend Favorite